Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - New York Stock Exchange, Inc. - US0126531013 - Common Stock - Currency: USD

70.98  -3.29 (-4.43%)

After market: 71.06 +0.08 (+0.11%)

Fundamental Rating

3

ALB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. Both the profitability and financial health of ALB have multiple concerns. While showing a medium growth rate, ALB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALB had negative earnings in the past year.
In the past year ALB had a positive cash flow from operations.
ALB had positive earnings in 4 of the past 5 years.
In the past 5 years ALB always reported a positive cash flow from operatings.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

ALB's Return On Assets of -7.69% is on the low side compared to the rest of the industry. ALB is outperformed by 74.12% of its industry peers.
ALB has a worse Return On Equity (-13.04%) than 71.76% of its industry peers.
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

The Gross Margin of ALB (3.53%) is worse than 87.06% of its industry peers.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALB has been increased compared to 5 years ago.
ALB has a better debt/assets ratio than last year.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.56, we must say that ALB is in the distress zone and has some risk of bankruptcy.
ALB has a worse Altman-Z score (1.56) than 64.71% of its industry peers.
ALB has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.31, ALB is doing good in the industry, outperforming 74.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACCN/A
WACC8.3%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

ALB has a Current Ratio of 2.11. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
ALB has a Current ratio (2.11) which is in line with its industry peers.
A Quick Ratio of 1.26 indicates that ALB should not have too much problems paying its short term obligations.
ALB has a Quick ratio of 1.26. This is comparable to the rest of the industry: ALB outperforms 52.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.26
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

ALB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.82%.
Looking at the last year, ALB shows a very negative growth in Revenue. The Revenue has decreased by -39.34% in the last year.
ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%

3.2 Future

ALB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.97% yearly.
ALB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.04% yearly.
EPS Next Y32.92%
EPS Next 2Y54.79%
EPS Next 3Y60.14%
EPS Next 5Y63.97%
Revenue Next Year-11.24%
Revenue Next 2Y-0.93%
Revenue Next 3Y4.92%
Revenue Next 5Y13.04%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 76.62, which means the current valuation is very expensive for ALB.
71.76% of the companies in the same industry are cheaper than ALB, based on the Price/Forward Earnings ratio.
ALB is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 76.62
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALB is valued a bit more expensive than 78.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 69.45
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALB's earnings are expected to grow with 60.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.79%
EPS Next 3Y60.14%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.18%, ALB has a reasonable but not impressive dividend return.
ALB's Dividend Yield is a higher than the industry average which is at 3.53.
ALB's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

The dividend of ALB is nicely growing with an annual growth rate of 13.04%!
ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-27.05%
EPS Next 2Y54.79%
EPS Next 3Y60.14%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

NYSE:ALB (7/11/2025, 8:04:00 PM)

After market: 71.06 +0.08 (+0.11%)

70.98

-3.29 (-4.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners98.3%
Inst Owner Change-0.01%
Ins Owners0.35%
Ins Owner Change16.84%
Market Cap8.35B
Analysts69.38
Price Target79.58 (12.12%)
Short Float %15.97%
Short Ratio5.49
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-27.05%
Div Incr Years30
Div Non Decr Years30
Ex-Date06-13 2025-06-13 (0.405)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-54.53%
Max EPS beat(2)69.72%
EPS beat(4)1
Avg EPS beat(4)-81.09%
Min EPS beat(4)-249.28%
Max EPS beat(4)69.72%
EPS beat(8)3
Avg EPS beat(8)-26.81%
EPS beat(12)7
Avg EPS beat(12)-12.91%
EPS beat(16)11
Avg EPS beat(16)-4.32%
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-7.88%
Revenue beat(4)1
Avg Revenue beat(4)-3.24%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.38%
PT rev (1m)-5.25%
PT rev (3m)-19.75%
EPS NQ rev (1m)-4.15%
EPS NQ rev (3m)-178.97%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-121.97%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-2.44%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-4.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 76.62
P/S 1.64
P/FCF N/A
P/OCF 7.27
P/B 0.83
P/tB 1.02
EV/EBITDA 69.45
EPS(TTM)-2.78
EYN/A
EPS(NY)0.93
Fwd EY1.31%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)9.77
OCFY13.76%
SpS43.29
BVpS85.23
TBVpS69.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.53%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 20.2
Cap/Depr 205.72%
Cap/Sales 25.31%
Interest Coverage N/A
Cash Conversion 742.04%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.26
Altman-Z 1.56
F-Score4
WACC8.3%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
EPS Next Y32.92%
EPS Next 2Y54.79%
EPS Next 3Y60.14%
EPS Next 5Y63.97%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%
Revenue Next Year-11.24%
Revenue Next 2Y-0.93%
Revenue Next 3Y4.92%
Revenue Next 5Y13.04%
EBIT growth 1Y40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.87%
EBIT Next 3Y44.72%
EBIT Next 5Y38.95%
FCF growth 1Y-114.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.55%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%